The ability to identify ovarian cancer (OC) at its earliest stages remains a challenge. The
patients present an advanced stage at diagnosis. This heterogeneous disease has …

Importance Ovarian cancer is relatively rare but the fifth-leading cause of cancer mortality
among United States women. Objective To systematically review evidence on benefits and …

Background The serum biomarker cancer antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care …

Importance Preeclampsia affects approximately 4% of pregnancies in the United States. It is
the second leading cause of maternal mortality worldwide and may lead to serious maternal …

Over three decades have passed since the first report on the expression of CA125 by
ovarian tumors. Since that time our understanding of ovarian cancer biology has changed …

Context Screening for ovarian cancer with cancer antigen 125 (CA-125) and transvaginal
ultrasound has an unknown effect on mortality. Objective To evaluate the effect of screening …

Simple Summary Ovarian high-grade serous carcinoma (HGSC) has a 5-year survival rate
of less than 50%, making it one of the most lethal gynecological cancers for women in the …

Inside the Sixth Edition of this now-classic reference, you will discover encyclopedic
coverage of topics ranging from basic science to sophisticated computer-based radiation …

A new paradigm for the pathogenesis of ovarian cancer has recently been proposed which
helps to explain persistent problems in describing the development and diverse morphology …

Background Ovarian cancer has a high case–fatality ratio, with most women not diagnosed
until the disease is in its advanced stages. The United Kingdom Collaborative Trial of …